Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study.

Borte, Michael

Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study. [electronic resource] - Journal of clinical immunology Dec 2011 - 952-61 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1573-2592

10.1007/s10875-011-9588-5 doi


Adolescent
Adult
Aged
Anti-Infective Agents--administration & dosage
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Immunoglobulin G--blood
Immunoglobulins--administration & dosage
Immunoglobulins, Intravenous--administration & dosage
Immunologic Deficiency Syndromes--blood
Infant
Injections, Subcutaneous
Italy
Male
Middle Aged
Prospective Studies